Clinical trials: First Line Treatment
Newly Diagnosed Immune Thrombocytopenia in Children, First Line Treatment
Two Regimens of IVIG in the Treatment of Newly Diagnosed ITP in Children
To compare the efficacy of two different dosage regimens of intravenous immune globulin (IVIG) in the treatment of children with newly diagnosed immune thrombocytopenia, and to reduce related adverse reactions and economic…
- Trial name
- NCT05520892
- Testing
- intravenous immunoglobulin
- Where
- China
- Volunteers
- 580 people
- Sponsor
- Fujian Medical University Union Hospital